- Title
- Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)
- Creator
- Ma, Christopher; Schoepfer, Alain M.; Dellon, Evan S.; Bredenoord, Albert J.; Chehade, Mirna; Collins, Margaret H.; Feagan, Brian G.; Furuta, Glenn T.; Gupta, Sandeep K.; Hirano, Ikuo; Jairath, Vipul; Katzka, David A.; Pai, Rish K.; Rothenberg, Marc E.; Straumann, Alex; Aceves, Seema S.; Alexander, Jeffrey A.; Arva, Nicoleta C.; Atkins, Dan; Biedermann, Luc; Blanchard, C; Cianferoni, A; Ciriza de Los Rios, C; Clayton, F; Davis, CM; de Bortoli, N; Dias, JA; Falk, GW; Genta, RM; Ghaffari, G; Gonsalves, N; Greuter, T; Hopp, R; Hsu Blatman, KS; Jensen, ET; Johnston, D; Kagalwalla, AF; Larsson, HM; Leung, J; Louis, H; Masterson, JC; Menard-Katcher, C; Menard-Katcher, PA; Moawad, FJ; Muir, AB; Mukkada, VA; Penagini, R; Pesek, RD; Peterson, K; Putnam, PE; Ravelli, A; Savarino, EV; Schlag, C; Schreiner, P; Simon, D; Smyrk, TC; Spergel, JM; Taft, TH; Terreehorst, I; Vanuytsel, T; Venter, C; Vieira, MC; Vieth, M; Vlieg-Boerstra, B; von Arnim, U; Walker, Marjorie M.; Wechsler, JB; Woodland, P; Woosley, JT; Yang, Guang-Yu; Zevit, N; Safroneeva, E
- Relation
- Journal of Allergy and Clinical Immunology Vol. 149, Issue 2, p. 659-670
- Publisher Link
- http://dx.doi.org/10.1016/j.jaci.2021.07.001
- Publisher
- Elsevier
- Resource Type
- journal article
- Date
- 2022
- Description
- Background: End points used to determine treatment efficacy in eosinophilic esophagitis (EoE) have evolved over time. With multiple novel therapies in development for EoE, harmonization of outcomes measures will facilitate evidence synthesis and appraisal when comparing different treatments. Objective: We sought to develop a core outcome set (COS) for controlled and observational studies of pharmacologic and diet interventions in adult and pediatric patients with EoE. Methods: Candidate outcomes were generated from systematic literature reviews and patient engagement interviews and surveys. Consensus was established using an iterative Delphi process, with items voted on using a 9-point Likert scale and with feedback from other participants to allow score refinement. Consensus meetings were held to ratify the outcome domains of importance and the core outcome measures. Stakeholders were recruited internationally and included adult and pediatric gastroenterologists, allergists, dieticians, pathologists, psychologists, researchers, and methodologists. Results: The COS consists of 4 outcome domains for controlled and observational studies: histopathology, endoscopy, patient-reported symptoms, and EoE-specific quality of life. A total of 69 stakeholders (response rate 95.8%) prioritized 42 outcomes in a 2-round Delphi process, and the final ratification meeting generated consensus on 33 outcome measures. These included measurement of the peak eosinophil count, Eosinophilic Esophagitis Histology Scoring System, Eosinophilic Esophagitis Endoscopic Reference Score, and patient-reported measures of dysphagia and quality of life. Conclusions: This interdisciplinary collaboration involving global stakeholders has produced a COS that can be applied to adult and pediatric studies of pharmacologic and diet therapies for EoE and will facilitate meaningful treatment comparisons and improve the quality of data synthesis.
- Subject
- eosinophilic esophagitis; outcomes; clincial trials; end points; histology; histopathology
- Identifier
- http://hdl.handle.net/1959.13/1453914
- Identifier
- uon:44768
- Identifier
- ISSN:0091-6749
- Rights
- © 2021 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
- Language
- eng
- Full Text
- Reviewed
- Hits: 41250
- Visitors: 41367
- Downloads: 202
| Thumbnail | File | Description | Size | Format | |||
|---|---|---|---|---|---|---|---|
| View Details Download | ATTACHMENT02 | Publisher version (open access) | 521 KB | Adobe Acrobat PDF | View Details Download |